secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolus, Inc. (EOLS)
CIK:        0001570562
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001570562-24-000038
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolus reports record Q4 revenue $61.0M (+40% YoY); guides to Q4 2024 profitability
--------------------------------------------------------------------------------

- Full-year 2023 net revenue $202.1M (+36% YoY); Q4 record $61.0M (+40% YoY).
- Q4 non-GAAP operating loss narrowed to $3.7M from $5.7M in Q3; full-year non-GAAP loss down 48% to $23.4M.
- Reaffirms 2024 revenue guidance $255-265M (26-31% growth); expects positive non-GAAP operating income in Q4 2024 and full year 2025.
- Added 840+ new Jeuveau accounts in Q4, total >12,400; loyalty program grew 55% to 750,000 members.
- Plans to file PMA for first two Evolysse fillers by mid-2024; targets at least $700M net revenue by 2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1570562/000157056224000038/0001570562-24-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1570562/000157056224000038/eols-20240307.htm
  HTML page:      https://secwatch.observer/filing/0001570562-24-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer